Below are the most recent publications written about "Stomach Neoplasms" by people in Profiles.
-
Zager Y, Goldes Y, Assaf D, Zilka N, Anteby R, Nevo Y, Barda L, Nevler A. Neutrophil to Lymphocyte Ratio in Patients Who Received Neoadjuvant Treatment before Gastrectomy. Isr Med Assoc J. 2023 May; 25(5):336-340.
-
Asif B, Sarvestani AL, Gamble LA, Samaranayake SG, Famiglietti AL, Fasaye GA, Quezado M, Miettinen M, Korman L, Koh C, Heller T, Davis JL. Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study. Lancet Oncol. 2023 04; 24(4):383-391.
-
Lamm R, Hewitt DB, Li M, Powell AC, Berger AC. Socioeconomic Status and Gastric Cancer Surgical Outcomes: A National Cancer Database Study. J Surg Res. 2022 07; 275:318-326.
-
Fisher BW, Jammula S, Wang S, Fluck M, Young K, Shabahang M, Blansfield J. Short-term Outcomes of Emergent Versus Elective Gastrectomy for Gastric Adenocarcinoma: A National Surgical Quality Improvement Program Study. Am Surg. 2023 May; 89(5):1758-1763.
-
Hitscherich KJ, Garg M, Petrelli NJ, Bennett JJ. Characteristics of Gastrointestinal Stromal Tumors incidentally discovered during abdominal surgery. Am J Surg. 2021 Nov; 222(5):983-988.
-
Giambra OM, Young KA, Buonpane CL, Dove JT, Shabahang MM, Blansfield J. Identifying Outlier Hospitals in Gastric Cancer Lymph Node Yield Using the National Cancer Database. J Surg Res. 2021 05; 261:196-204.
-
Curtin BF, Gamble LA, Schueler SA, Ruff SM, Quezado M, Miettinen M, Fasaye GA, Passi M, Hernandez JM, Heller T, Koh C, Davis JL. Enhanced endoscopic detection of occult gastric cancer in carriers of pathogenic CDH1 variants. J Gastroenterol. 2021 02; 56(2):139-146.
-
Fisher BW, Fluck M, Young K, Shabahang M, Blansfield J, Arora TK. Urgent Surgery for Gastric Adenocarcinoma: A?Study of the National Cancer Database. J Surg Res. 2020 01; 245:619-628.
-
Jayanathan M, Erwin RP, Molacek N, Fluck M, Hunsinger M, Wild J, Arora TK, Shabahang MM, Franko J, Blansfield JA. MAGIC versus MacDonald treatment regimens for gastric cancer: Trends and predictors of multimodal therapy for gastric cancer using?the National Cancer Database. Am J Surg. 2020 01; 219(1):129-135.
-
Lo W, Zhu B, Sabesan A, Wu HH, Powers A, Sorber RA, Ravichandran S, Chen I, McDuffie LA, Quadri HS, Beane JD, Calzone K, Miettinen MM, Hewitt SM, Koh C, Heller T, Wacholder S, Rudloff U. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC). J Med Genet. 2019 06; 56(6):370-379.